Olanzapine for chemotherapy-induced nausea and vomiting control

[...]cutoffs for non-inferiority margins are not defined by regulatory authorities and are instead subject to clinical decision making.4 Most clinicians would like to retain at least half of the benefit seen with the intervention in the pivotal trial. In the seminal olanzapine study, in the overall...

Ausführliche Beschreibung